CVS vs CNC Stock Comparison

Cvs Health and Centene Prices as of Nov 13, 2026 Peers: Industry group
CVS CVS HEALTH Corp
$89.33 -1.2% 1M +12.7% 1Y
Market cap
$114.34B
P/E
10.4x
Revenue (TTM)
$420.61B
Div. yield
2.99%
Managed Care Healthcare
7 wins
CNC Centene Corp
$71.26 +1.6% 1M +97.5% 1Y
Market cap
$35.04B
P/E
–
Revenue (TTM)
$194.78B
Div. yield
–
Managed Care Healthcare
3 wins

Head to Head

10 decided of 12

Cvs Health leads on 7 of the 12 questions below (Cvs Health 7, Centene 3). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCVSCNCLeader
Larger companyMarket capitalisation $114.34B $35.04B CVS
Cheaper on earningsLower P/E, profitable companies only 10.4x -5.3x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 10.2x 13.1x CVS
Faster revenue growthRevenue growth, trailing twelve months +6.7% +19.4% CNC
More profitableNet margin, trailing twelve months 2.6% -3.4% CVS
Better return on capitalReturn on invested capital 9.7% -19.9% CVS
Less leveragedLower net debt / EBITDA 2.3x 0.0x CNC
Higher dividend yieldTrailing dividend yield 2.99% — –
Better 1-year returnPrice return, last 12 months +12.7% +97.5% CNC
Better 5-year returnAnnualised price return, 5 years -1.0%/yr -1.2%/yr CVS
Less volatileAnnualised volatility, 1 year 35.1% 46.4% CVS
Higher overall scoreMean of the five percentile scores vs peers 72/100 51/100 CVS

Percentile Scorecard

CVSCNC

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCVSCNC
Valuation 100 #1 of 27 92 #3 of 27
Growth 80 #6 of 26 28 #19 of 26
Profitability 84 #5 of 26 36 #17 of 26
Financial Health 24 #20 of 26 36 #17 of 26
Shareholder Returns 71 #6 of 18 65 #7 of 18
Overall 72 51
  • CVS ranked among 27 companies in Healthcare Payers and Distributors
  • CNC ranked among 27 companies in Healthcare Payers and Distributors

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCVSCNCSPY
1 month -1.2%+1.6% -2.0%
3 months -8.1%+5.6% -2.8%
6 months -6.8%+22.3% +2.0%
Year to date +12.6%+73.2% +10.6%
1 year +12.7%+97.5% +12.2%
3 years +30.4%-2.7% +68.1%
3 years, per year +9.3%-0.9% +18.9%
5 years -5.0%-6.1% +61.4%
5 years, per year -1.0%-1.2% +10.1%
10 years +19.0%+181.2% +248.5%
10 years, per year +1.8%+10.9% +13.3%

Risk

MeasureCVSCNCSPY
Volatility, 1Y 35.1%46.4% 13.6%
Downside volatility, 1Y 38.8%45.1% 13.9%
Beta vs S&P 500, 1Y -0.050.46 1.00
Return / volatility, 1Y 0.362.10 0.90
Max drawdown, 5Y -60.5%-74.1% -25.4%
From 52-week high -19.2%-6.2% -3.2%
52-week high $110.55$75.99 $779.14
52-week low $70.08$31.80 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCVSCNC
P/E now vs peer median 10.4xmedian 25.2x -5.3xmedian 25.2x
P/S now vs peer median 0.3xmedian 0.4x 0.2xmedian 0.4x
EV/EBITDA now vs peer median 8.2xmedian 14.5x 0.2xmedian 14.5x
P/FCF now vs peer median 7.3xmedian 16.5x 8.1xmedian 16.5x
P/B now vs peer median 1.4xmedian 2.7x 1.7xmedian 2.7x
PEG now vs peer median 1.22median 1.72 0.05median 1.72

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCVSCNC
Revenue $420.61B $194.78B
Gross profit $186.06B $37.08B
Operating income $15.06B -$7.62B
Net income $11.09B -$6.68B
Free cash flow $15.57B $4.32B
EPS (diluted) $8.55 $-13.53
Cash & equivalents $11.74B $17.89B
Total debt $60.68B $17.40B
Shares (diluted) 1.29B 493.12M
Enterprise value $63.29B -$39.00B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCVSCNC
P/E 10.4x -5.3x
P/FCF 7.3x 8.1x
P/Operating cash flow 6.1x 6.9x
P/S 0.3x 0.2x
P/B 1.4x 1.7x
P/Tangible book 2.0x 2.3x
EV/EBITDA 8.2x 0.2x
EV/EBIT 10.6x -4.2x
EV/Revenue 0.4x 0.2x
EV/FCF 10.3x 7.4x
EV/Operating cash flow 8.6x 6.3x
PEG (3Y EPS CAGR) 1.22 0.05

Growth

14 metrics
MetricCVSCNC
Revenue growth (1Y) 6.7% 19.4%
Revenue CAGR (3Y) 6.5% 10.5%
Gross profit growth (1Y) 5.3% -0.8%
Gross profit CAGR (3Y) 10.9% 3.9%
Operating income growth (1Y) 206.4% -340.1%
Operating income CAGR (3Y) 2.4% -98.2%
Net income growth (1Y) 2,369% -302.0%
Net income CAGR (3Y) 8.6% -96.3%
EPS growth (1Y) 2,213% -314.5%
EPS CAGR (3Y) 8.5% -104.5%
Operating cash flow growth (1Y) 105.4% 3,204%
Operating cash flow CAGR (3Y) 9.9% -6.7%
Free cash flow growth (1Y) 147.4% 981.8%
Free cash flow CAGR (3Y) 11.3% -6.3%

Profitability

14 metrics
MetricCVSCNC
Gross margin 44.2% 19.0%
EBITDA margin 4.7% 84.8%
Operating margin 3.6% -3.9%
Pretax margin 2.9% -3.5%
Net margin 2.6% -3.4%
FCF margin 3.7% 2.2%
Operating cash flow margin 4.4% 2.6%
Return on equity 13.8% -32.5%
Return on assets 4.3% -8.4%
Return on invested capital 9.7% -19.9%
Return on capital employed 9.2% -17.9%
Asset turnover 1.6x 2.5x
Cash conversion (OCF / net income) 1.7x -0.8x
Stock comp / revenue 0.2% 0.1%

Financial Health

11 metrics
MetricCVSCNC
Debt / assets 23.5% 22.7%
Debt / equity 0.8x 0.9x
Net debt / EBITDA 2.3x 0.0x
Debt / FCF 3.9x 4.0x
Liabilities / assets 68.7% 73.9%
Equity / assets 31.3% 26.1%
Interest coverage 4.9x -11.2x
Current ratio 0.9x 1.1x
Quick ratio 0.8x 1.0x
Cash ratio 0.2x 0.6x
Altman Z-score 2.51 2.80

Shareholder Returns

7 metrics
MetricCVSCNC
Dividend yield 3.0% –
Net buyback yield -0.4% 1.2%
Shareholder yield 2.6% 1.2%
Payout ratio (earnings) – –
Payout ratio (FCF) – –
Dividend growth (1Y) – –
Dividend CAGR (3Y) – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCVSCNC
Forward P/E 10.2xFY2026 13.1xFY2026
EPS, next fiscal year $8.80FY2026 $5.44FY2026
EPS growth, next FY +30.4%FY2026 +161.5%FY2026
EPS growth, the year after +1.1% +8.1%
Revenue, next fiscal year $431.16BFY2026 $206.34BFY2026
Revenue growth, next FY +7.2%FY2026 +5.9%FY2026
Revenue growth, the year after -5.3% -1.2%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCVSCNC
Held by institutions 89.1% 97.9%
Institutions holding 2,074 1,001
Change in shares held, QoQ +3.5% +2.1%
Institutions buying 1,103 569
Institutions selling 733 334
Buyers to sellers 1.50 1.70

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CVSCNC
CVS 1.00 0.32
CNC 0.32 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, CVS and CNC?

Cvs Health (CVS) is the largest by market capitalisation: Cvs Health (CVS) $114.34B, Centene (CNC) $35.04B.

Which company is growing faster?

Centene (CNC) grew revenue fastest over the trailing twelve months: Cvs Health (CVS) +6.7%, Centene (CNC) +19.4%.

Which company is more profitable?

Cvs Health (CVS) has the highest net margin (Cvs Health (CVS) 2.6%, Centene (CNC) -3.4%). On return on invested capital, Cvs Health (CVS) leads (Cvs Health (CVS) 9.7%, Centene (CNC) -19.9%).

Which stock has performed better?

Over the past year Centene (CNC) returned the most: Cvs Health (CVS) +12.7%, Centene (CNC) +97.5%. Over five years, Cvs Health (CVS) compounded fastest (Cvs Health (CVS) -1.0%/yr, Centene (CNC) -1.2%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Cvs Health (CVS) 2.99%. Centene (CNC) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Cvs Health (CVS) has been the steadiest (Cvs Health (CVS) 35.1%, Centene (CNC) 46.4%). Volatility measures how widely the price swings, not the risk of the business.

Do CVS and CNC move together?

Their daily returns over the past year have a correlation of 0.32, a weak relationship. Holding both diversifies more than two closely linked stocks would.

Which is the better stock, CVS and CNC?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Cvs Health (CVS) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.